Table 2 Patients’ and tumor characteristics among recipients with and without recurring hepatocellular carcinoma
Tumor recurrence (n = 20) | Recurrence-free (n = 111) | p | |
|---|---|---|---|
Age (years) | 55 [29–64] | 59 [34–70] | 0.0255 |
Male gender (%) | 65.0 | 78.4 | 0.2516 |
MELD score | 10 [7–40] | 11 [6–36] | 0.3888 |
Etiology of liver disease | 0.3226 | ||
Alcohol (%) | 15.0 | 26.1 | |
Hepatitis B (%) | 30.0 | 12.6 | |
Hepatitis C (%) | 35.0 | 43.3 | |
NASH (%) | 10.0 | 10.8 | |
Other (%) | 10.0 | 4.5 | |
Within Milan criteria (%) | 35.0 | 53.2 | 0.1522 |
AFP pre-treatment (U/mL) | 101.3 [3.6–7454.0] | 14.2 [1.0–13,923.0] | 0.0036 |
Poor differentiation G3 (%) | 25.0 | 8.1 | 0.0402 |
Microvascular invasion V1 (%) | 45.0 | 4.5 | < 0.0001 |
Complete necrosis (%) | 5.0 | 52.3 | < 0.0001 |